Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 15Prostatic Neoplasms 13Neoplasms 4Breast Neoplasms 4Vaginal Neoplasms 2Uterine Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Endometrial Clear Cell Adenocarcinoma 2Vulvar Neoplasms 1Stage IA Uterine Sarcoma 1Radiation Injuries 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Obesity 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Liver Neoplasms 1Fatigue 1Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1Endometrial Adenocarcinoma 1Desmoplastic Small Round Cell Tumor 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Breast Carcinoma In Situ 1Biliary Tract Neoplasms 1

Interventions

Cisplatin 3fludarabine phosphate 2fludarabine 2aldesleukin 2Radiation 2Platinum 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Cyclophosphamide 2Congresses as Topic 2Brachytherapy 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 21,2-diaminocyclohexaneplatinum II citrate 2rocakinogene sifuplasmid 1durvalumab 1alovudine 1adavosertib 1Vaccines, Synthetic 1VGX-3100 1Sonazoid 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiosurgery 1Magnetic Resonance Spectroscopy 1MEDI0457 1Interleukin-2 1Immunoglobulin G 1Fondaparinux 1Fluorodeoxyglucose F18 1Fentanyl 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Vaginal Neoplasms × Brachytherapy × Clear all
NCT02466971 2026-06-15

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

National Cancer Institute (NCI)

Phase 3 Active not recruiting
450 enrolled 11 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT01399658 2023-03-14

AMIGO

Dana-Farber Cancer Institute

Phase 2 Completed
93 enrolled 5 charts
Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡